Milad Shirvaliloo
Genetics — Tabriz University of Medical Sciences, Iran
Milad Shirvaliloo
LeadR Profile
Genetics
Subspecialties: Biochemistry - Oncology - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Organizations
Career arc: 2023 - 2026
Number : 52
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Targeting the undruggable in glioblastoma using nano-based intracellular drug delivery. cells, pharmaceutical preparations, hyperthermia, brain, neoplasms, drug therapy, glioblastoma, therapeutics, chemotherapy | Med Oncol | 2024 | 3 |
| Sydenham's Chorea in Children with Acute Rheumatic Fever: An Echocardiographic Survey of Pediatric Patients in Northwestern Iran. rheumatic fever, streptococcal infections, prevalence, sex, chorea, child | Iran J Med Sci | 2024 | 1 |
| Dual-drug delivery by thermo-responsive Janus nanogel for improved cellular uptake, sustained release, and combination chemo-thermal therapy. technology, pharmaceutical, brain, pharmaceutical preparations, cells, therapeutics, fluorouracil, neoplasms, nanoparticles | Int J Pharm | 2024 | 6 |
| Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity. risk, history, chemistry, pharmaceutical, drug design, percutaneous coronary intervention, covid-19 | Curr Med Chem | 2023 | 3 |
| Expression and promoter methylation of mitogen-activated protein kinase 1 in tumor and marginal cells of breast cancer. breast diseases, biomarkers, mitogens, cells, breast neoplasms, mitogen-activated protein kinase 1, mitogen-activated protein kinases, promoter regions, genetic | Breast Dis | 2023 | 0 |
LeadR Networks
Main global connection map